Eli Lilly commits $470m towards new US manufacturing plant
Eli Lilly is set to invest around $470m to build a pharmaceutical manufacturing plant at...
Read More...
Focus:
-
![Tepezza FDA approval]()
Horizon Therapeutics gets FDA approval for thyroid eye disease drug
Irish pharmaceutical company Horizon Therapeutics has received the US Food and Drug Administration (FDA) approval...
Read More...
-
![Coronavirus US case]()
Coronavirus: CDC confirms first US case; search for cure underway
The Centers for Disease Control and Prevention (CDC) in the US has reported the first...
Read More...
-
![Coronavirus]()
Coronavirus: US scientists work on vaccine; WHO to determine severity
Scientists at the National Institutes of Health (NIH) in the US have already started working...
Read More...
-
![US scientists discover anti-cancer use for non-oncology drugs]()
US scientists discover anti-cancer use for non-oncology drugs
Researchers at the Broad Institute of MIT and Harvard have worked with Dana-Farber Cancer Institute...
Read More...
-
![Novartis’ Mayzent]()
EC approves Novartis multiple sclerosis drug Mayzent
The European Commission (EC) has approved Novartis’ Mayzent (siponimod) to treat secondary progressive multiple sclerosis...
Read More...
-
![AstraZeneca gets orphan drug status for Imfinzi in liver cancer in US]()
AstraZeneca gets orphan drug status for Imfinzi in liver cancer in US
AstraZeneca has received orphan drug designation (ODD) from the US Food and Drug Administration (FDA)...
Read More...
-
![J&J’s Risperdal lawsuit]()
US judge cuts damages in J&J’s Risperdal case from $8bn to $6.8m
Judge Kenneth Powell of the Philadelphia Court of Common Pleas, US has reduced the $8bn...
Read More...
-
![UK NICE says more data required to approve Bayer’s Vitrakvi]()
UK NICE says more data required to approve Bayer’s Vitrakvi
The National Institute for Health and Care Excellence (NICE) in the UK has not recommended...
Read More...
-
WuXi Biologics to acquire drug manufacturing plant in Germany
WuXi Biologics has signed an acquisition agreement to take over a Bayer’s drug product manufacturing...
Read More...